Alexion Pharmaceuticals’ flagship drug has made a strong case it can treat yet another rare disease, and the company is
Category Archives: Uncategorized
Research Headlines – Blue e-infrastructure to inform blue growth policy
[Source: Research & Innovation] Without a clear view of marine resources and environments, efforts to derive sustainable growth from the
UN Proposals to Weaken IP Will Not Benefit Patients
Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in New York City. Among the
35 Behind-The-Scenes Facts You Probably Didn’t Know About “American Horror Story”
On Wednesdays we wear black! View Entire Post ›
Equillium Plans IPO to Fund Clinical Trials for Transplant Drug
Equillium, a biotech startup developing treatments for immune system disorders-including an immune response that affects some transplant recipients-is preparing for
GMOs: Responding to the Issue of Food Waste and Loss
Food waste and food loss is a hot topic right now and rightly so. The United Nations has set a
SR One’s Brian Gallagher Jumps to Abingworth for Partner Post
Brian Gallagher is joining London-based Abingworth as a partner based in the life sciences investment firm’s Boston office. Gallagher comes
‘Cultural and creative cities for all’- Knowledge Exchange Platform workshop – 11 October 2018, Brussels, Belgium
[Source: Research & Innovation] Are you curious to know how integrating immigrants can contribute to the revitalisation of historic centres?
Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly
Elanco is now a standalone company after raising $1.5 billion in its stock market debut. Greenfield, IN-based Elanco (NYSE: ELAN)
2018-2020 Mobility for Growth
[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-MG-2018-2019-2020Pillar: Societal ChallengesOpening Date: Deadline: Wed, 31 Jan 2018 17:00:00 (Brussels local time)Modification Date: Thu, 20 Sep